2000至2019年医疗保险脊髓刺激器使用与报销的最新趋势
本研究利用2000至2019年公开的联邦医疗保险B部分全国汇总数据,分析经皮与开放放置脊髓刺激器(CPT 63650与63655)的使用量与医生报销趋势。结果显示两类手术量及每次手术报销额均逐年上升。
要点
- 2000至2019年联邦医疗保险批准的经皮脊髓刺激器手术共992372例,开放手术共99736例。
- 经皮手术量年均增长21.9%,开放手术量年均增长18.4%。
- 每次经皮手术报销年均增长8.7%,每次开放手术报销年均增长9.1%。
核心结论
- 2000至2019年经皮与开放脊髓刺激器手术数量稳步增加,每次手术报销额同期也稳步上升。
- 识别这些趋势有助于推动手术费用研究并确保充足的资源分配。
研究设计与样本
- 研究使用公开的联邦医疗保险B部分全国汇总数据文件,覆盖2000至2019年所有向联邦医疗保险计费的服务。
- 数据包含每项服务的现行程序术语(CPT)编码、执行次数及每年医生计费总额与报销额。
- 研究识别经皮放置编码63650与开放放置编码63655,按年分离总允许服务数、允许费用与实际支付额。
- 将每年允许费用与实际支付额除以总允许服务数,得到并分析每例经皮与开放放置手术的允许费用和实际支付额。
主要发现
- 2000至2019年联邦医疗保险批准的经皮脊髓刺激器手术共992372例,开放脊髓刺激器手术共99736例。
- 2000至2019年联邦医疗保险批准的经皮脊髓刺激器放置手术年均增长21.9%,开放脊髓刺激器放置手术年均增长18.4%。
- 同期每次经皮脊髓刺激器放置手术的联邦医疗保险报销年均增长8.7%,每次开放脊髓刺激器放置手术的报销年均增长9.1%。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spinal cord stimulators (SCS) allow spine surgeons to provide relief for patients who suffer from chronic pain due to several disorders, such as failed back surgery syndrome, complex regional pain syndrome, and neuropathy. Despite this, there remains a paucity of data regarding the utilization and reimbursement of SCS. Therefore, the purpose of this study is to evaluate the monetary and procedural trends of spinal cord stimulators among the Medicare database from 2000 to 2019. METHODS: Medicare Part B National Summary Data files, which are publicly available, were used. These files contain data from the years 2000-2019 on all services billed to Medicare within that time frame. Each service is given a Current Procedural Terminology (CPT) code and the number of times that service was performed, as well as the total physician Medicare charges and reimbursements for each service annually are included in that data set. The CPT codes for percutaneous and open placement of spinal cord stimulators were identified: 63650 and 63655, respectively. The total allowed services allowed charges and actual payments were isolated from the data set for each year for each CPT code. The total allowed charges and actual payments for the year were then divided by the total allowed services to find and trend the allowed charges and actual payment for each individual service performed for both percutaneous and open placement of spinal cord stimulators. RESULTS: There were 992,372 Medicare-approved total percutaneous spinal cord stimulator operations and 99,736 Medicare-approved total open spinal cord stimulator operations from 2000 to 2019. Medicare paid $1.02 billion (2019 U.S. dollars) in reimbursement to physicians for percutaneous spinal cord stimulator operations and nearly $145 million (2019 U.S. dollars) in reimbursement to physicians for open spinal cord stimulator operations. From the years 2000 to 2019, there was an average 21.9% increase annually in Medicare-approved percutaneous spinal stimulator placement operations and a 18.4% increase annually in Medicare-approved open spinal stimulator placement operations. During this time, there was also an average 8.7% increase annually in Medicare reimbursement per each percutaneous spinal stimulator placement operation and a 9.1% increase annually in Medicare reimbursement per each open spinal stimulator placement operation. CONCLUSIONS: The results of this study show that the number of percutaneous and open procedures have steadily increased from 2000 to 2019. Reimbursement per procedure has also increased steadily over this time. Identifying these trends is important to promote research into costs of these surgeries and ensure adequate resource allocation.
引用
- Romaniuk M, Mahdi G, Singh R, et al. Recent Trends in Medicare Utilization and Reimbursement for Spinal Cord Stimulators: 2000-2019. World Neurosurg. 2022. PMID: 35872133. doi:10.1016/j.wneu.2022.07.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。